Skip to content
O

Olaniyi David Ogundeji

Publications (3)

Esmethadone in Major Depressive Disorder: Pharmacology and Clinical Evidence

Olaniyi David Ogundeji, Nkechinyere M Harry, Akinyemi Akinwumiju, Obianuju Nwauwa, Gibson Anugwom & Samuel Nwaobi · Journal of Advances in Medicine and Medical Research · 2025

Major Depressive Disorder (MDD) affects approximately 280 million people globally, with current treatments showing significant limitations, including delayed onset of action, low remission rates, and troublesome side effects. Esmethadone (REL-1017, d-methadone) has emerged as a p...

Open access Research Article 10.9734/jammr/2025/v37i85919

High-Potency Cannabis, Early Use, and the Risk of Psychosis in Adolescents

Hafiz Olatunde, Rajkumar Patel, Adadioramma Okonkwo, Adeolu Funso Oladunjoye, Omotola Emmanuel, Olaniyi David Ogundeji, Oluwafeyikemi Fasina & James B. McKenzie · Journal of Advances in Medicine and Medical Research · 2025

Cannabis is the most widely used illicit substance globally, with an estimated 244 million people reporting its use in 2025. Cannabis remains the most widely used illicit substance globally, and its increasing prevalence among adolescents has raised critical public health concern...

Open access Research Article 10.9734/jammr/2025/v37i115976

Transcranial Magnetic Stimulation for the Rehabilitation of Broca's Aphasia: A Review of Current Protocols and Clinical Outcomes

Gibson Anugwom, Nkechinyere Mary Harry, Afolarin Ishola, Obianuju Nwauwa, Akinyemi Akinwumiju & Olaniyi David Ogundeji · Journal of Advances in Medicine and Medical Research · 2025

Stroke constitutes a leading global cause of long-term disability, leaving a significant percentage of survivors with persistent neurological deficits that compromise their independence and quality of life. Post-stroke Broca's aphasia represents a significant source of chronic di...

Open access Research Article 10.9734/jammr/2025/v37i75889